We deliver end-to-end CDMO solutions within Pharmaceutical Development & Manufacturing, advancing through Drug Substance Development to specialized Cytokine Development. Our stem cell factor (SCF) programs emphasize rigorous analytics, study-ready materials, and platformable methods aligned with phase-appropriate quality expectations.
Overview of Stem Cell Factor (SCF) Development
Stem cell factor (SCF, KIT ligand) is a disulfide-rich glycoprotein that engages the receptor tyrosine kinase c-Kit. Its development requires careful control of folding, disulfide pairing, glycosylation, and aggregation, all of which influence potency and stability in laboratory systems. We build SCF programs around clear target product profiles for the drug substance, then translate them into upstream expression strategies, refolding or secretion controls, and orthogonal purification schemes.
Fig.1 Structure of stem cell factor (SCF).
Our Services
We provide a coherent set of SCF-focused CDMO services spanning pharmaceutical development & manufacturing, drug substance development, and cytokine development. The offering centers on process design, analytical science, functional and bioassays—purpose-built for SCF rather than general protein platforms.
SCF Process Development Service
We design expression and purification strategies tailored to SCF's biophysics. For microbial expression, we deploy inclusion-body refolding matrices that optimize redox environment, protein concentration, and refold kinetics. For mammalian expression, we configure secretory pathways and feed strategies to tune glycan profiles and minimize proteolysis. Downstream, we construct orthogonal trains combining capture (ion exchange or affinity), disulfide-sensitive polishing, and size-exclusion or multimodal steps to manage dimers and higher aggregates.
SCF Analytical Development Service
We establish an assay suite that de-risks development and underpins specifications. Typical packages combine intact-mass and peptide-map LC–MS for identity and disulfide mapping; capillary electrophoresis or HPLC for purity and charge variants; SEC-MALS for aggregation and molecular mass; circular dichroism or DSC for secondary/tertiary structure; and glycan profiling for mammalian-expressed SCF.
SCF Bioassay & Potency Service
To quantify function, we configure c-Kit–linked bioassays with clear acceptance criteria and system-suitability controls. Formats include cell-signaling readouts (e.g., phosphorylation-based endpoints) or reporter responses that reflect pathway engagement. Reference standard strategy, curve modeling, parallelism assessment, and inter-assay precision are defined early to ensure longitudinal comparability across development lots. Where appropriate, orthogonal biochemical surrogates (e.g., receptor-ligand binding kinetics) are added to support trending.
SCF Impurity & Aggregation Control Service
Given SCF's sensitivity to oxidation and mispairing, we implement targeted controls for process- and product-related impurities. This includes host-cell protein and DNA monitoring, proteolytic fragment detection, and orthogonal aggregate measurement (SEC-MALS, AUC where needed). We map oxidative hotspots and define antioxidant/redox guardrails to minimize artifacts during purification, storage, and handling.
SCF Protein Engineering & Variant Screening Service
For programs exploring manufacturing-friendly or study-optimized variants, we design rational mutations that preserve function while improving expression, folding efficiency, or colloidal stability. Workstreams can include signal-peptide swaps, pro-region and linker tuning, removal of labile residues, and evaluation of soluble versus membrane-anchored-mimetic formats.
Our Stem Cell Factor (SCF) Portfolio
Our development services support commonly used SCF categories, including but not limited to:
- Recombinant human SCF (soluble)
- Recombinant murine and rat SCF
- Monomeric vs. dimer-favoring preparations
- Mammalian-expressed glycosylated SCF
- …
- Tag-managed SCF research formats
- Engineered stability variants
- Membrane-proximal mimetic constructs
- Microbial-expressed refolded SCF
We specialize in SCF drug-substance development—uniting process design, analytics, and bioassays into a single, phase-appropriate program. Partner with us to accelerate SCF into a robust, study-ready form with reproducible quality.
Our products and services are for research use only.
